Zum Hauptinhalt springen

International

01. Januar 2024 | International

ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids

ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids Weimer, Melissa B. DO, MCR, DFASAM; Herring, Andrew A. MD; Kawasaki, Sarah S. MD, FASAM; Meyer, Marjorie MD; Kleykam...

01. Januar 2024 | International

Management of opioid use disorders: a national clinical practice guideline

Management of opioid use disorders: a national clinical practice guideline Julie Bruneau, Keith Ahamad, Marie-Ève Goyer, Ginette Poulin, Peter Selby, Benedikt Fischer, T. Cameron Wild and Evan Wood; on behalf of the CIHR Canadian Research Initiat...

12. Dezember 2023 | International

USA. Advisory: Low Barrier Models of Care for Substance Use Disorders

USA. Advisory: Low Barrier Models of Care for Substance Use Disorders The Advisory outlines the principles and components of low barrier care, and how low barrier care may be leveraged to overcome substantial gaps in access, while also engaging i...

30. November 2023 | International

WHO. Neuer Leitfaden der Weltgesundheitsorganisation zur psychischen Gesundheit

WHO. Neuer Leitfaden der Weltgesundheitsorganisation zur psychischen Gesundheit Genf – Die Weltgesundheitsorganisation (WHO) hat die dritte Auflage ihre Leitfadens für ein Aktionsprogramm zu psychischer Gesundheit vorgestellt (Mental ...

30. November 2023 | International

WHO. Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders - Third edition

WHO. Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders - Third edition The mhGAP guideline supports countries to strengthen capacity to deal with the growing burden of mental, neurological a...

30. November 2023 | International

EMCDDA. Prevention and control of infectious diseases among people who inject drugs — 2023 update

EMCDDA. Prevention and control of infectious diseases among people who inject drugs — 2023 update This joint guidance report explores good public health practices that can support effective policies to reduce infections. Common blood-borne ...

30. November 2023 | International

EMCDDA. Women and drugs: health and social responses

EMCDDA. Women and drugs: health and social responses This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide. It provides an overview of the most important aspects to consider ...

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten